High-dose cytarabine chemotherapy (≥4 g/m2/day) before allogeneic hematopoietic stem cell transplantation for non-core-binding-factor AML in the first complete remission
| Image |  |
|---|---|
| Description | scientific article published on 17 August 2020 |
| Author/s |
author: Tadakazu Kondo |
| Publication date | August 17, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |